Inspire IVF Public Company (IVF) Fair Value & Analysis
Healthcare · TH · Market cap 273M THB
Fair value as of: Jul 16, 2026
From 1 valuation models · updated today
Fair value updated Jul 16, 2026 — revised from 3.60 THB to 0.9100 THB (−74.7%) since Jun 24, 2026. Share price +18.8% over the past month.
Price vs Fair Value (12 months)
12‑month range 0.5400 THB – 1.10 THB · fair‑value band 0.6000 THB – 1.14 THB · the 0.7600 THB price screens below the 0.9100 THB fair value. As of Jul 16, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Inspire IVF Public Company (IVF) currently trades at 0.7600 THB, while our model-based Fair Value estimate is 0.9100 THB — implying the stock looks roughly 19.7% undervalued today. We read business quality at 31/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
Over the trailing twelve months, Inspire IVF Public Company generated revenue of 65.9M THB at a net margin of -32.8%. Revenue declined 20.9% year over year. It earns a return on equity of -4.0%. Net debt stands at 11.5M THB. Fundamentals as of Jul 16, 2026
Our scenario range runs from 0.6000 THB (bear case) to 1.14 THB (bull case); at 0.7600 THB, the current price sits within that range. The share trades about 35% below its 52-week high and 52% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at 0% fair-value upside — at 20%, IVF screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 16, 2026. TTM = trailing twelve months.
About the company
Inspire IVF Public Company Limited operates an infertility treatment center in Thailand. It offers intrauterine insemination, preimplantation genetic testing, intracytoplasmic sperm injection, embryo transfer, fertility preservation, preventive and regenerative medicine, health checkup, and other infertility treatments. The company provides obstetrics and gynecology examinations, consulting, and advice, as well as age management medicine, health regeneration, blood dialysis, and blood filtration services. Inspire IVF Public Company Limited was incorporated in 2018 and is based in Bangkok, Thailand.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Inspire IVF Public Company reported revenue of 61.9M THB in FY2025 versus 11.2M THB in FY2021, a compound +53.2%/yr. Reported net income was −17.4M THB in FY2025.
Is IVF fairly valued? → Check now
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 16, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc H1CA34 | R$97.60 | R$115.75 | +19% |
| Fresenius SE FSNUY | $11.27 | $8.25 | -27% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.76 SGD | 1.28 SGD | -54% |
| DaVita Inc DVA | $209.68 | $255.97 | +22% |
| Rede D'Or São Luiz S.A RDOR3 | R$32.76 | R$30.33 | -7% |
| Tenet Healthcare Corporation THC | $164.77 | $280.85 | +70% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,489 | ₹2,128 | -75% |
| Fresenius Medical Care AG FME | €37.19 | €60.51 | +63% |
| Aier Eye Hospital Group 300015 | ¥8.54 | ¥6.73 | -21% |
| Bangkok Dusit Medical Services Public Company BDUUF | $0.6400 | $0.6400 | +0% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Inspire IVF Public Company (IVF) undervalued?
What is the fair value of IVF?
What is the quality score of IVF?
What is the revenue of Inspire IVF Public Company (IVF)?
What is the net profit margin of IVF?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Unlock the full Inspire IVF Public Company analysis — and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.